HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase.

Abstract
Excessive hepatic gluconeogenesis and glucose production are important contributors to hyperglycemia in both type 1 and type 2 diabetes. In diabetic humans and animal models, elevated levels of p38 mitogen-activated protein kinase (p38) are observed in several tissues. Our study shows that activity of p38 is significantly elevated in livers of db/db or streptozocin-induced type 1 diabetic mice. Using cultured hepatoma cells, we find that activation of p38 enhances expression of hepatic gluconeogenic gene phosphoenolpyruvate carboxykinase (PEPCK). Furthermore, our studies demonstrate that activation of p38 stimulates phosphorylation of CCAAT/enhancer-binding protein alpha (C/EBPalpha) at serine 21 and increases its transactivation activity in the context of PEPCK gene transcription. Our results indicate that C/EBPalpha mediates p38-stimulated PEPCK transcription in liver cells.
AuthorsLiping Qiao, Ormond A MacDougald, Jianhua Shao
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 281 Issue 34 Pg. 24390-7 (Aug 25 2006) ISSN: 0021-9258 [Print] United States
PMID16807249 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CCAAT-Enhancer-Binding Protein-alpha
  • p38 Mitogen-Activated Protein Kinases
  • Phosphoenolpyruvate Carboxykinase (ATP)
Topics
  • Animals
  • CCAAT-Enhancer-Binding Protein-alpha (metabolism)
  • Cell Line, Tumor
  • Diabetes Mellitus, Experimental (metabolism)
  • Diabetes Mellitus, Type 1 (metabolism)
  • Enzyme Activation
  • Humans
  • Liver (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Phosphoenolpyruvate Carboxykinase (ATP) (metabolism)
  • Phosphorylation
  • Promoter Regions, Genetic
  • Transcriptional Activation
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: